Deutsche Bank downgraded Amedisys to Hold from Buy with a $101 price target. The analyst believes Amedisys’ recent divestiture of certain home health assets signals progress towards the Optum takeover closure this year.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMED:
- Amedisys Releases Q2 Supplemental Financial Slides
- Amedisys reports Q2 adjusted EPS $1.32, consensus $1.18
- Birkenstock upgraded, Charter initiated: Wall Street’s top analyst calls
- William Blair downgrades Amedisys on tighter takeover spread
- Amedisys, UnitedHealth to divest home health care centers to VitalCaring